Myalept
NDC 10122-210, metreleptin, injection, powder, lyophilized, for solution, from Chiesi USA, Inc..
- Product NDC
- 10122-210
- Status
- Listed
- Labeler
- Chiesi USA, Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125390
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10122-210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METRELEPTIN11.3 mg/2.2mL
Pharmacologic classes
Analogs/Derivatives [Chemical/Ingredient]; Leptin Analog [EPC]; Leptin [Chemical/Ingredient]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10122-210-02 | 10122021002 | 1 VIAL, GLASS in 1 CARTON (10122-210-02) / 2.2 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d3b50bbd-140b-425c-b5ec-d4682aad62bc
Use it
Look up 10122-210 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10122-210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10122-210. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.